Zoological Institute, Russian Academy of Sciences, Universitetskaya nab. 1, 199034 St. Petersburg, Russia.
Department of Pharmacology and Clinical Pharmacology, Saint Petersburg State Chemical Pharmaceutical University, 197022 St. Petersburg, Russia.
Cells. 2021 Apr 21;10(5):976. doi: 10.3390/cells10050976.
Chronic hepatitises of various etiologies are widespread liver diseases in humans. Their final stage, liver cirrhosis (LC), is considered to be one of the main causes of hepatocellular carcinoma (HCC). About 80-90% of all HCC cases develop in LC patients, which suggests that cirrhotic conditions play a crucial role in the process of hepatocarcinogenesis. Carbohydrate metabolism in LC undergoes profound disturbances characterized by altered glycogen metabolism. Unfortunately, data on the glycogen content in LC are few and contradictory. In this study, the material was obtained from liver biopsies of patients with LC of viral and alcohol etiology and from the liver tissue of rats with CCl-induced LC. The activity of glycogen phosphorylase (GP), glycogen synthase (GS), and glucose-6-phosphatase (G6Pase) was investigated in human and rat liver tissue by biochemical methods. Total glycogen and its labile and stable fractions were measured in isolated individual hepatocytes, using the cytofluorometry technique of PAS reaction in situ. The development of LC in human and rat liver was accompanied by an increase in fibrous tissue (20- and 8.8-fold), an increase in the dry mass of hepatocytes (by 25.6% and 23.7%), and a decrease in the number of hepatocytes (by 50% and 28%), respectively. The rearrangement of the liver parenchyma was combined with changes in glycogen metabolism. The present study showed a significant increase in the glycogen content in the hepatocytes of the human and the rat cirrhotic liver, by 255% and 210%, respectively. An increased glycogen content in cells of the cirrhotic liver can be explained by a decrease in glycogenolysis due to a decreased activity of G6Pase and GP.
各种病因引起的慢性肝炎是人类中广泛存在的肝脏疾病。其终末期病变——肝硬化(LC)被认为是肝细胞癌(HCC)的主要病因之一。大约 80-90%的 HCC 病例发生在 LC 患者中,这表明肝硬化状态在肝癌发生过程中起着至关重要的作用。LC 中的碳水化合物代谢发生了深刻的紊乱,表现为糖原代谢改变。不幸的是,关于 LC 中糖原含量的数据很少且相互矛盾。在这项研究中,我们获得了病毒性和酒精性 LC 患者的肝活检组织以及 CCl 诱导的 LC 大鼠的肝组织。通过生化方法研究了人肝和鼠肝组织中糖原磷酸化酶(GP)、糖原合酶(GS)和葡萄糖-6-磷酸酶(G6Pase)的活性。使用 PAS 反应的细胞荧光术原位技术,在分离的单个肝细胞中测量了总糖原及其不稳定和稳定的分数。在人类和大鼠的 LC 发展过程中,纤维组织增加(分别增加了 20 倍和 8.8 倍)、肝细胞干重增加(分别增加了 25.6%和 23.7%)、肝细胞数量减少(分别减少了 50%和 28%)。肝实质的重排与糖原代谢的变化相结合。本研究表明,人类和大鼠肝硬化肝组织中糖原含量分别显著增加了 255%和 210%。由于 G6Pase 和 GP 活性降低导致糖原分解减少,因此肝硬化细胞中糖原含量增加。